Drugs / NOVOCART® Disc plus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01640457 | Aug 2012 → Nov 2018 | intervertebral disk degenerative disorder | Tetec AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NOVOCART Disc plus | “NOVOCART® Disc plus (NDplus, 60 subjects)” NCT01640457 ↗ |
| Known as | NDplus | “NOVOCART® Disc plus (NDplus, 60 subjects)” NCT01640457 ↗ |
| Modality | Cell therapy | “NOVOCART™ Disc plus, an autologous cell compound for autologous disc chondrocyte transplantation” PMID 26920137 ↗ Feb 2016 |